158 related articles for article (PubMed ID: 2149280)
21. Idoxifene: report of a phase I study in patients with metastatic breast cancer.
Coombes RC; Haynes BP; Dowsett M; Quigley M; English J; Judson IR; Griggs LJ; Potter GA; McCague R; Jarman M
Cancer Res; 1995 Mar; 55(5):1070-4. PubMed ID: 7866990
[TBL] [Abstract][Full Text] [Related]
22. Phase I and II studies of toremifene.
Hamm JT
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):19-22. PubMed ID: 9165502
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication.
Modig H; Borgström S; Nilsson I; Westman G
J Steroid Biochem; 1990 Jun; 36(3):235-6. PubMed ID: 2142242
[TBL] [Abstract][Full Text] [Related]
24. [The anti-estrogenic effect of 4-chloro-1,2-diphenyl-1-(4-[2-(N,N-dimethylamino)ethoxy]phenyl)1-butene (Toremifene) on the endocrine regulation in breast cancer patients].
Számel I; Hindy I; Vincze B; Ady N; Eckhardt S
Orv Hetil; 1991 Mar; 132(13):683-6. PubMed ID: 1826556
[TBL] [Abstract][Full Text] [Related]
25. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
Gundersen S
J Steroid Biochem; 1990 Jun; 36(3):233-4. PubMed ID: 2142241
[TBL] [Abstract][Full Text] [Related]
26. Hormonal effects of toremifene in breast cancer patients.
Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients.
Ellmén J; Werner D; Hakulinen P; Keiling R; Fargeot P; Falkson G; Bezwoda WR
Cancer Chemother Pharmacol; 2000; 45(5):402-8. PubMed ID: 10803924
[TBL] [Abstract][Full Text] [Related]
28. Review of the pharmacological properties of toremifene.
Kangas L
J Steroid Biochem; 1990 Jun; 36(3):191-5. PubMed ID: 2142231
[TBL] [Abstract][Full Text] [Related]
29. A phase I trial of toremifene, a new antiestrogen.
Hamm JT
Cancer Invest; 1990; 8(2):273-4. PubMed ID: 2144786
[No Abstract] [Full Text] [Related]
30. Effect of toremifene in breast cancer patients. Preliminary communication.
Hindy I; Juhos E; Szántó J; Számel I
J Steroid Biochem; 1990 Jun; 36(3):225-6. PubMed ID: 2142238
[TBL] [Abstract][Full Text] [Related]
31. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study.
Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Thölix E; Nordman E; Taskinen P; Holsti L; Hajba A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):785-90. PubMed ID: 2968265
[TBL] [Abstract][Full Text] [Related]
32. Introduction to toremifene.
Kangas L
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S3-7. PubMed ID: 2149282
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.
Kisanga ER; Gjerde J; Guerrieri-Gonzaga A; Pigatto F; Pesci-Feltri A; Robertson C; Serrano D; Pelosi G; Decensi A; Lien EA
Clin Cancer Res; 2004 Apr; 10(7):2336-43. PubMed ID: 15073109
[TBL] [Abstract][Full Text] [Related]
34. Development and biochemical pharmacology of toremifene, an antiestrogenic antitumor drug.
Kangas L
Acta Obstet Gynecol Scand; 1991; 70(4-5):399. PubMed ID: 1836089
[No Abstract] [Full Text] [Related]
35. Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study.
Kivinen S; Mäenpää J
J Steroid Biochem; 1990 Jun; 36(3):217-20. PubMed ID: 2142236
[TBL] [Abstract][Full Text] [Related]
36. Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal women.
Mäenpää J; Söderström KO; Grönroos M; Taina E; Hajba A; Kangas L
J Steroid Biochem; 1990 Jun; 36(3):221-3. PubMed ID: 2142237
[TBL] [Abstract][Full Text] [Related]
37. Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
O'Regan RM; Cisneros A; England GM; MacGregor JI; Muenzner HD; Assikis VJ; Bilimoria MM; Piette M; Dragan YP; Pitot HC; Chatterton R; Jordan VC
J Natl Cancer Inst; 1998 Oct; 90(20):1552-8. PubMed ID: 9790548
[TBL] [Abstract][Full Text] [Related]
38. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
[TBL] [Abstract][Full Text] [Related]
39. Toremifene and letrozole for advanced breast cancer.
Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
[No Abstract] [Full Text] [Related]
40. European early phase II dose-finding study of droloxifene in advanced breast cancer.
Bellmunt J; Solé L
Am J Clin Oncol; 1991; 14 Suppl 2():S36-9. PubMed ID: 1962595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
